Showing results (1-10 of 501) with videos related to
Sort By:
Pageof 51
Clinical Pharmacokinetics|May 1, 1979
Corticosteroid pharmacokinetics in liver diseaseM Uribe, V L GoJournal of Clinical Gastroenterology|August 1, 1984
Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effectsM Uribe, V L Go, D KlugeClinical Pharmacokinetics|September 1, 1982
Comparative serum prednisone and prednisolone concentrations following administration to patients with chronic active liver diseaseM Uribe, W H Summerskill, V L GoGut|December 1, 1978
Oral prednisone for chronic active liver disease: dose responses and bioavailability studiesM Uribe, S W Schalm, W H Summerskill, et al.Gastroenterology|August 1, 1976
Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisoneM Uribe, S W Schalm, W H Summerskill, et al.Gastroenterology|April 1, 1981
Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteersM Uribe, C Casian, S Rojas, et al.Cancer|December 1, 1982
The role of tumor markers in the management of colorectal cancerV L Go, N ZamcheckPeptides|January 1, 1981
Role of nutrients in the gastrointestinal release of immunoreactive neurotensinV L Go, P DemolPancreas|May 1, 1994
Regulation of polyunsaturated fatty acid-stimulated insulin release by GIP in isolated perifused isletsE C Opara, V L GoPageof 51